Healthtech Startups

Neuralert develops a patented algorithm and wearable technology aimed at early stroke detection. The company operates in the medical device and digital health space, with ties to University of Pennsylvania neurology research.

1 investor

NeuralTeks develops AI-powered tools for laboratory analysis, specifically targeting microbiology and microbial identification in pharmaceutical, biotechnology, and analytical settings. The platform aims to accelerate analysis speed, improve accuracy, and reduce costs for laboratory operations.

1 investor

Neuraly is a clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative disorders, focusing on inhibiting pathological glial activation to prevent neuronal cell death. Its lead candidate NLY01 has been evaluated in Phase 2 trials for early Parkinson's disease.

1 investor

NeuraVue provides AI-powered monitoring systems for senior care facilities and independent living settings, detecting falls, wandering, and distress to alert caregivers and family members in real time. The platform serves independent living communities, assisted living facilities, skilled nursing homes, and aging-in-place scenarios, with specialized capabilities for dementia care.

1 investor

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.

1 investor

Neurescue develops a medical device that treats cardiac arrest patients by inserting a balloon-occlusion device through the femoral artery to increase blood flow to the heart and brain during chest compressions. The device targets patients ineligible for defibrillation and uses automated pressure-limited inflation to improve resuscitation outcomes.

1 investor

Neurobiome LLC is developing the M.E. Gut-Brain chip, a microfluidic screening tool that uses dynamic flow and high-throughput testing to identify microbiome-mediated neuroactive compounds and probiotic strains. It targets early-stage screening for probiotic and pharmaceutical development aimed at mental and neurological health conditions.

1 investor

Neurobit analyzes physiological signals recorded during sleep to identify patterns associated with cardiovascular disease, stroke, and dementia risk. Its AI models are trained on more than a trillion data points of multi-channel physiological data and are designed to work across different devices, signal types, and patient populations. The company's aim is a health analytics platform that treats sleep as a general-purpose biomarker for clinicians and researchers.

1 investor

Neurochase provides consultancy to biotech and pharmaceutical companies on directly delivering therapies to the central nervous system, drawing on experience with catheter infusions and convection-enhanced delivery. It supports preclinical study protocols, toxicology, surgical workflow and training, and is developing its own CED drug-delivery devices.

1 investor

Neurodon develops small-molecule therapeutics that target cellular calcium imbalance and the endoplasmic reticulum stress pathway, using compounds that allosterically modulate the SERCA enzyme to restore calcium transport. Its disease-modifying approach aims at conditions linked to cellular stress such as diabetes, Alzheimer's, Parkinson's, and Duchenne muscular dystrophy.

1 investor

NeuroEquilibrium operates a network of clinics specializing in diagnosis and treatment of vertigo, dizziness, and balance disorders through a deep-tech platform that integrates cloud technology, computer vision, and remote diagnostics. The company serves patients and healthcare providers in India and globally, aiming to standardize care for vestibular disorders.

1 investor

Neurofit is a web-based cognitive rehabilitation platform that enables clinicians to assign adaptive cognitive activities, track client performance data, and generate clinical reports for insurance claims. It serves occupational therapists, speech-language pathologists, neuropsychologists, and rehabilitation medicine professionals treating clients across the lifespan.

1 investor

NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.

1 investor

NeuroGenesis develops cell therapies for neurodegenerative diseases, leveraging its NG CELL platform to enhance stem cells for treating conditions like multiple sclerosis and ALS. The company is advancing Phase IIb clinical trials in Europe and Israel with a focus on remyelinating and regenerative cellular medicine.

1 investor

NeuroHive develops digital health monitoring and precision livestock farming tools for farmers, combining veterinary expertise with software engineering to track animal health in real-time.

1 investor

Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain. It serves eye-care patients across all ages through providers, offering Single Vision, Office, and Progressive lens designs.

1 investor

Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development. Its lead program, NLV-01, is built on protein-engineering technology contributed by co-founding partner LifeArc.

1 investor

Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus. Its device is available through clinics across Europe and the United States and has been studied in large-scale clinical trials.

1 investor

Neuronity develops therapies that enhance immune cell activity in the aging brain to prevent neurodegenerative disease progression. The company targets patients with age-related neurological conditions.

1 investor

1 investor

NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.

1 investor

1 investor

NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders. Its Monarch eTNS System is an FDA-cleared, prescription home-use device for treating pediatric ADHD in children ages 7 to 12, with additional programs targeting conditions such as autism spectrum disorder, epilepsy, and depression.</parameter> <parameter name="founders">[]

1 investor

NeuroSky provides biofeedback and biometric assessment solutions that help companies optimize hiring decisions, identify employee training needs, and improve workforce productivity through data-driven insights on cognitive performance and employee capabilities.

1 investor